KALA
Kala Pharmaceuticals Inc
-9.01%
$16.65 - $15.15
Feb 7th 2023 - Mar 21st 2023
Jan, 9, 2023
$KALA is the one up 500% on Phase 2 results where ... See more
Jan, 4, 2023
$CTMX $KALA the next big runner after approval tomorrow wow! !
HTGM
HTG Molecular Diagnostics Inc
-37.26%
$4.67 - $2.93
Feb 7th 2023 - Mar 21st 2023
Jan, 13, 2023
$HTGM is over 100% since yesterday, looks for a go... See more
Dec, 27, 2022
Plus it is expecting more positive catalysts in we... See more
Jan, 9, 2023
$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.
Jan, 4, 2023
$CTMX $KALA the next big runner after approval tomorrow wow! !
Dec, 28, 2022
$KALA FDA approved!
Dec, 28, 2022
Successful development and potential approval for KPI-012 will be a huge boost for the company.
Jan, 13, 2023
$HTGM is over 100% since yesterday, looks for a good entry $KERN had a lot of volume yesterday $1.5 can be a good entry $VYNE announce split has been approved by board and can be executed at any time
Dec, 27, 2022
Plus it is expecting more positive catalysts in weeks and months: 5 year data for breast cancer, Canada approval, China commercialziation, and much more.
Dec, 14, 2022
FDA approved.